Drug Type AAV based gene therapy |
Synonyms LY M003, LYM003 |
Target |
Action stimulants |
Mechanism ATP7B gene stimulants(ATPase copper transporting beta gene stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
RegulationOrphan Drug (United States), Rare Pediatric Disease (United States) |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hepatolenticular Degeneration | Phase 2 | China | 27 May 2026 |





